Lista de obras - Heidi Fiegl - Dominio Público Uruguay

A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer

artículo científico publicado en 2004

A concept of a MIABIS based register of biosample collections at the Medical University of Innsbruck

artículo científico publicado en 2014

Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer

artículo científico publicado en 2010

Analysis of methylated genes in peritoneal fluids of ovarian cancer patients: a new prognostic tool

scientific article published on 01 November 2004

Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen.

artículo científico publicado en 2004

Attenuation of cell adhesion in lymphocytes is regulated by CYTIP, a protein which mediates signal complex sequestration

artículo científico publicado en 2003

BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer

artículo científico publicado en 2018

Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer.

artículo científico publicado en 2006

CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients

scientific article published on 01 March 2004

Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers.

artículo científico publicado en 2007

Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer Patients ⬇️

artículo científico publicado el 5 de julio de 2012

Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer.

artículo científico publicado en 2016

Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens

scientific article published on 29 October 2018

DNA hypomethylation and ovarian cancer biology.

artículo científico publicado en 2004

DNA methylation changes in sera of women in early pregnancy are similar to those in advanced breast cancer patients

scientific article published on 01 June 2004

DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery.

artículo científico publicado en 2009

DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer ⬇️

artículo científico publicado el 20 de enero de 2011

Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.

artículo científico publicado en 2006

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab

artículo científico publicado en 2015

Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1.

artículo científico publicado en 2017

E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.

artículo científico publicado en 2010

Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients

artículo científico publicado en 2011

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens ⬇️

artículo científico publicado el 26 de marzo de 2013

Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation ⬇️

artículo científico publicado el 27 de marzo de 2012

Epigenetics in the perioperative period

artículo científico publicado en 2015

Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study

artículo científico publicado en 2008

Evaluating L1CAM expression in human endometrial cancer using qRT-PCR.

scientific article published on 24 May 2016

Evaluation of Vav3.1 as prognostic marker in endometrial cancer

artículo científico publicado en 2018

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers.

artículo científico publicado en 2016

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.

artículo científico publicado en 2016

FBXW7/hCDC4 is a general tumor suppressor in human cancer.

artículo científico publicado en 2007

FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.

artículo científico publicado en 2017

FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma

artículo científico publicado en 2012

GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer.

artículo científico publicado en 2013

HE4 is an independent prognostic marker in endometrial cancer patients ⬇️

artículo científico publicado el 21 de abril de 2012

HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

artículo científico publicado en 2015

HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer

scientific article published on 01 August 2008

High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing

artículo científico publicado en 2015

High prevalence of side population in human cancer cell lines

artículo científico publicado en 2016

In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors

artículo científico publicado en 2014

Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality

scientific article published on 03 August 2018

Interferon-gamma expression is an independent prognostic factor in ovarian cancer.

artículo científico publicado en 2004

Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer.

artículo científico publicado en 2009

KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients

artículo científico publicado en 2016

Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro

artículo científico publicado en 2014

Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro.

artículo científico publicado en 2012

Long non-coding RNAs as targets for cytosine methylation.

artículo científico publicado en 2013

MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status ⬇️

artículo científico publicado el 17 de noviembre de 2003

Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.

artículo científico publicado en 2008

Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.

artículo científico publicado en 2004

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.

artículo científico publicado en 2017

Mutual antagonism of TGF-beta and Interleukin-2 in cell survival and lineage commitment of induced regulatory T cells.

artículo científico publicado en 2012

NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer

scientific article published on 01 February 2019

Ovarian cancer stem cells.

artículo científico

Prognostic DNA methylation marker in serum of cancer patients

scientific article published on 01 June 2004

Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.

artículo científico publicado en 2016

Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer

artículo científico publicado en 2011

Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development

scientific journal article

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma

artículo científico publicado en 2014

SFRP2 methylation in fecal DNA--a marker for colorectal polyps

scientific article published on 17 July 2007

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.

artículo científico publicado en 2015

The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancer

artículo científico publicado en 2012

The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer

artículo científico publicado en 2012

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

artículo científico publicado en 2005

Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

artículo científico publicado en 2010

Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer

artículo científico publicado en 2019

miR-21-3p is a positive regulator of L1CAM in several human carcinomas.

artículo científico publicado en 2014

Lista de obras de Heidi Fiegl

A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer

A concept of a MIABIS based register of biosample collections at the Medical University of Innsbruck

Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer

Analysis of methylated genes in peritoneal fluids of ovarian cancer patients: a new prognostic tool

Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen.

Attenuation of cell adhesion in lymphocytes is regulated by CYTIP, a protein which mediates signal complex sequestration

BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer

Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer.

CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients

Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers.

Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer Patients ⬇️

Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer.

Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens

DNA hypomethylation and ovarian cancer biology.

DNA methylation changes in sera of women in early pregnancy are similar to those in advanced breast cancer patients

DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery.

DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer ⬇️

Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab

Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1.

E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.

Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens ⬇️

Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation ⬇️

Epigenetics in the perioperative period

Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study

Evaluating L1CAM expression in human endometrial cancer using qRT-PCR.

Evaluation of Vav3.1 as prognostic marker in endometrial cancer

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers.

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.

FBXW7/hCDC4 is a general tumor suppressor in human cancer.

FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.

FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma

GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer.

HE4 is an independent prognostic marker in endometrial cancer patients ⬇️

HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer

High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing

High prevalence of side population in human cancer cell lines

In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors

Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality

Interferon-gamma expression is an independent prognostic factor in ovarian cancer.

Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer.

KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients

Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro

Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro.

Long non-coding RNAs as targets for cytosine methylation.

MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status ⬇️

Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.

Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.

Mutual antagonism of TGF-beta and Interleukin-2 in cell survival and lineage commitment of induced regulatory T cells.

NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer

Ovarian cancer stem cells.

Prognostic DNA methylation marker in serum of cancer patients

Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.

Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer

Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma

SFRP2 methylation in fecal DNA--a marker for colorectal polyps

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.

The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancer

The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer

miR-21-3p is a positive regulator of L1CAM in several human carcinomas.